BAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Baxter International Inc (BAX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, neutral sentiment from hedge funds and insiders, and mixed financial performance. While there are some positive catalysts like revenue growth and partnerships, the company's negative earnings, margin pressures, and underwhelming guidance make it a less attractive option currently. Holding off on buying is recommended until clearer positive trends emerge.
The technical indicators show a bearish trend. The MACD is negative and contracting, RSI is neutral at 39.067, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading near its support level of 16.237, with resistance at 18.128.
The Baxter Foundation's partnership with Pet Partners could enhance the company's brand and reach. Supply constraints are expected to resolve by 2026.
Net income remains negative at -$1.13 billion, despite improvement. Gross margin dropped significantly by 45.16% YoY. Analysts have consistently lowered price targets, citing margin pressures and underwhelming guidance. The stock's price has declined by 2.63% in the regular market session.
In Q4 2025, revenue grew by 8.03% YoY to $2.97 billion. However, net income was -$1.13 billion, showing a 120.31% YoY increase but still negative. EPS improved to -2.2, up 120% YoY. Gross margin dropped significantly to 20.24%, down 45.16% YoY, indicating operational challenges.
Analysts have a neutral to cautious stance on BAX. Price targets have been consistently lowered, with the current range between $17 and $25. Analysts cite margin pressures, underwhelming guidance, and limited near-term visibility as concerns.
